patent.fyi
Applications  /  US 2026/0354960
United States Patent Application Publication

US 2026/0354960 A1

Published
Nov 12, 2026
Filed
Oct 27, 2023
Earliest date on the face
Oct 28, 2022
Classification
A61F 2/04
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Dense film carries cells

What ifWhat if a continuous, nonporous film carried the therapeutic cells?
Claim language“a porous scaffold”

A dense silicone film carries a covalently bound fibronectin coating that supports an adherent cell monolayer. The coated face contacts the wound bed, where oxygen and dissolved nutrients reach the cells by diffusion.

1.1Scaffold recruits resident cells

What ifWhat if an acellular scaffold recruited cells from adjacent tissue after placement?
Claim language“hosting a population of therapeutic cells”

An interconnected collagen foam is placed against viable tissue without cell seeding. Resident cells migrate into the hydrated foam from the wound margins and deposit extracellular matrix as the collagen degrades.

1.1Fiber bundles fill defects

What ifWhat if a volume-filling fiber bundle carried cells throughout a defect without distinct inner and outer faces?
Claim language“an outer surface and an inner surface”

Crimped biodegradable polyester fibers form an open, three-dimensional bundle that conforms to an irregular tissue cavity. Cells attach to collagen-coated fibers throughout the bundle, and inter-fiber channels admit tissue fluid.

1.2Adhesion retains seeded cells

What ifWhat if the median pore size exceeded the limiting median cell dimension and surface adhesion retained the cells?
Claim language“is less than a limiting median dimension”

A collagen-coated polyester lattice has a median opening of 250 micrometers for a cell population with a limiting median dimension of 20 micrometers. The lattice is immersed in a cell suspension during seeding, and cells attach to the coated struts before excess suspension is drained.

1.2Hydrogel immobilizes encapsulated cells

What ifWhat if a continuous hydrogel immobilized the cells through polymer cross-linking without a defined population of cell-scale pores?
Claim language“a median pore size in the porous scaffold”

Cells are dispersed in an aqueous gelatin derivative and immobilized by visible-light cross-linking. Oxygen and dissolved nutrients diffuse through the hydrated network, and enzymatic cleavage of the gelatin allows local remodeling.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Cell retention sleeve for cultured muscle

A porous cellulose sleeve lines a flow chamber used to grow animal muscle cells for food research. The surface facing the chamber bore carries the cells, and the outer surface faces an annular medium channel. The sleeve has a median pore opening smaller than the median minimum width of the suspended cells. Medium flows through the annular channel, and dissolved nutrients diffuse through the sleeve to the cells.

Component substitution

Porous titanium scaffold for airway repair

A sintered titanium fiber mesh forms the porous wall of a segmental airway prosthesis. A contoured mandrel defines the inner surface, and a forming die sets the outer surface and wall thickness. The median through-pore constriction is smaller than the median minimum width of the suspended airway epithelial cells. A thin collagen coating on the inner surface supports cell attachment while leaving connected pores open.

Perforated foil scaffold for bladder repair

A laser-perforated tantalum foil forms a curved patch with inner and outer surfaces separated by the foil thickness. Circular through-holes follow a staggered array, and their median diameter is smaller than the median minimum width of the suspended urothelial cells. The cell-bearing inner surface faces the bladder lumen, and the outer surface faces the surrounding tissue. A separate row of larger suture holes along the solid perimeter secures the patch at the repair site.

Parameter or scale variation

Tubular scaffold with graded pore sizes

A 6 mm inner-diameter tube has a 450 µm wall made from two bonded porous cellulose layers. The 150 µm inner layer has a median pore opening of 4 µm, and the 300 µm outer layer has a median pore opening of 8 µm. Both medians are smaller than the measured median minimum width of 12 µm for the suspended cell population. Cells attach to the inner surface, and the larger outer pores provide a lower-resistance path for medium entering from the outside.

Combination with existing systems

Scaffold in a dual circuit bioreactor

A tubular scaffold mounts between two sealed end fittings in a dual circuit perfusion bioreactor. One pump circulates medium through the bore, and a second pump circulates medium through the chamber around the outer surface. The median pore constriction is smaller than the median minimum width of the cells carried on the bore surface. Pressure sensors at the two outlets provide feedback to keep the pressure difference across the wall near zero while both circuits circulate medium.

Automated or data-driven variant

Image guided selection of scaffold pores

An automated microscope images suspended cells from each preparation, and segmentation software calculates the median of their minimum projected widths. A capillary flow porometer measures the median through-pore constriction of witness coupons made alongside each scaffold batch. The controller assigns the cell preparation to a batch with a measured pore median below the measured cell median and records both values. A dispensing stage rotates the selected scaffold while a nozzle places the cells along its inner surface.

Specific version of a part

Electrospun tubular cell scaffold

Biodegradable polyester fibers are electrospun onto a rotating cylindrical mandrel to form a porous tube with a 0.5-millimeter wall. After the mandrel is removed, a collagen coating on the lumen-facing surface supports cell attachment.

Freeze-dried collagen sheet

A collagen slurry freezes in a flat mold, and sublimation of the ice leaves a porous sheet with a nominal thickness of 1 millimeter. One face receives a cell suspension, and the opposite face contacts the supporting tissue.

Fine pores support surface seeding

A porous polyester scaffold has a median pore opening of 5 micrometers for a cell population with a limiting median dimension of 16 micrometers. A fibronectin coating supports attachment of seeded cells along the scaffold face while the pores permit solute transport.

Controlled pores in polyethylene

Sintered polyethylene particles form a rigid scaffold with a median pore opening of 8 micrometers for a cell population with a limiting median dimension of 22 micrometers. A collagen coating supports attachment at the exposed surface and around the pore entrances.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 8,114,806 B2
Published
Feb 14, 2012
Filed
Apr 10, 2009
Class
B01J 21/00
Document BUS 2021/0178017 A1
Published
Jun 17, 2021
Filed
Feb 5, 2021
Class
A61L 27/227
Claim 1
Document A
Document B
1.1a porous scaffold adapted for hosting a population of therapeutic cells, the porous scaffold comprising an outer surface and an inner surface separated by a thickness; and
The catalyst includes an porous alumina support containing less than or equal to 2.5 wt % silica on a finished catalyst basis, and bearing 2.2 wt % to 6 wt % of a Group VIII metal oxide, 7 wt % to 24 wt % of a Group VIB metal oxide and preferably less than 0.2 wt % of a phosphorous oxide.
A · US 8,114,806 B2 · ¶ 9
In some embodiments, the composition can further comprise an agent. In some embodiments, agent can be selected from the group consisting of: an antibiotic; an agent to attract cells; a cell; a stem cell; a ligand; a growth factor; a platelet; and a component of extracellular matrix.
B · US 2021/0178017 A1 · ¶ 6
1.2wherein a median pore size in the porous scaffold is less than a limiting median dimension for the population of therapeutic cells.
The pore size of the pourous layer can vary, e.g. accordingly to the size and/or shape of the cells and/or tissue which will be regenerated.
B · US 2021/0178017 A1 · ¶ 44

An empty cell means only that no passage was reproduced there.

Statements in these documents
It would be desirable to have a process and/or catalyst for reducing the viscosity of a disadvantaged crude at selected temperatures and minimal pressures.
A · US 8,114,806 B2 · ¶ 5
Such a catalyst could be used at elevated temperatures and minimal pressures.
A · US 8,114,806 B2 · ¶ 5
However, existing scaffolds, while permitting a certain level of tissue regeneration lead to long-term graft failure due to implant contracture, graft rupture, and/or fibrosis.
B · US 2021/0178017 A1 · ¶ 4
The layers of these compositions differ in their physical properties and provide a complete composition that serves both as a scaffold for tissue regeneration as well as a suturable substrate capable of sealing a wound or tissue defect.
B · US 2021/0178017 A1 · ¶ 5
Cite aspatent.fyi, US 2026/0354960 A1, claim 1, first published 2026-11-19T06:07:06-05:00, https://patent.fyi/US20260354960/, SHA-256 ba52b4df718c10d47c7bde11460c1e2e7da86f4fb62610bd5d3a12e487199e34
First published
Permanent addresshttps://patent.fyi/US20260354960/
Content fingerprint (SHA-256)ba52b4df718c10d47c7bde11460c1e2e7da86f4fb62610bd5d3a12e487199e34
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi